Comprehensive Biomarker Discovery Platform Reveals Qualified MRM Assay for Prediction of INF/Ribavirin Treatment Response in Hepatitis C Patients

The current standard of care for chronic Hepatitis C (CHC) results in sustained viral response in only half of patients and also has significant side effects. Improved pre-treatment clinical predictors of response are needed to individualize treatment and select individuals most appropriate for new...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dubois, L.G., Patel, K., Lucas, J.E., McCarthy, J., McHutchison, J.G., Moseley, M.A., Thompson, J.W.
Formato: Artigo
Lenguaje:Inglês
Publicado: Association of Biomolecular Resource Facilities 2011
Materias:
Poster Session Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186590/
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares